/PRNewswire/ Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a robust collection of new clinical and real-world data on.
Medtronic Announces Scientific Data Presentations at the 14th International Conference on Advanced Technologies & Treatments for Diabetes
News provided by
Share this article
DUBLIN, June 1, 2021 /PRNewswire/
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its virtual participation at the 14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), taking place June 2-5, 2021. Medtronic will showcase clinically meaningful outcomes associated with the company s comprehensive product portfolio and future technologies, as well as customer-centric support and services provided in a remote environment during the COVID-19 pandemic, including onboarding and training for healthcare providers and patients.
Scientific Presentations
New No Fingerstick 1 Sensor Integrates with Both the MiniMed 780G System and the Smart InPen System Medtronic plc the global leader in medical technology, today announced CE Mark for expanded functionality of the company's InPen™ smart 2 insulin pen for multiple daily injections . The company also announced CE Mark for its Guardian™ 4 sensor 3 which requires no fingersticks 1 for calibration or diabetes .
Medtronic Secures Two CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.